IRIS

Sfoglia per ???browse.type.metadata.subjectIsicrui???  Oncologia

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 20 di 394
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2020 18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up D'Angelillo, R; Fiore, M; Trodella, L; Sciuto, R; Ippolito, E; Carnevale, A; Iurato, A; Miele, M; Trecca, P; Trodella, L; Greco, C; Ramella, S Articolo su rivista
1-gen-2005 5-Fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine Correale, P; Del Vecchio, M; Di Genova, G; Savellini, G; La Placa, M; Terrosi, C; Vestri, M; Urso, R; Lemonnier, F; Aquino, A; Bonmassar, E; Giorgi, G; Francini, G; Cusi, Mg Articolo su rivista
1-gen-2002 A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report Aquino, A; Prete, S; Balduzzi, A; Fossile, E; Formica, V; Torino, F; Bonmassar, L; Di Giacomo, A; Cappelletti, D; Cardillo, A; Graziani, G Articolo su rivista
1-ott-2021 Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment? Franzese, O; Torino, F; Giannetti, E; Cioccoloni, G; Aquino, A; Faraoni, I; Fuggetta, Mp; De Vecchis, L; Giuliani, A; Kaina, B; Bonmassar, E Articolo su rivista
1-gen-2022 Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy. Verzoni, E; Pappagallo, G; Alongi, F; Arcangeli, S; Francolini, G; Galanti, D; Galli, L; Maruzzo, M; Rossetti, S; Siepe, G; Triggiani, L; Zucali, P; D'Angelillo, R Articolo su rivista
3-apr-2022 Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review Iannantuono, Gm; Riondino, S; Sganga, S; Roselli, M; Torino, F Articolo su rivista
1-gen-2013 Aderenza alle cure: un tema di pertinenza anche infermieristica Prandi, C; Vellone, E; De Marinis, M; Alvaro, R Articolo su rivista
1-gen-2001 Adjuvant chemotherapy for stage IB non-small cell lung cancer Ambrogi, V; Mariotti, S; Roselli, M; Mineo, Tc Intervento a convegno
10-apr-2010 Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data Arriagada, R; Auperin, A; Burdett, S; Higgins, J; Johnson, D; Le Chevalier, T; Le Pechoux, C; Mineo, Tc; Parmar, M; Pignon, J; Souhami, R; Stephens, R; Stewart, L; Tierney, J; Tribodet, H; van Meerbeeck, J Articolo su rivista
1-dic-2021 Adjuvant radiotherapy and radioiodine treatment for locally advanced differentiated thyroid cancer: systematic review and meta-analysis Dicuonzo, S; Pedretti, S; Mangoni, M; Monari, F; Fanetti, G; Borsatti, E; Lombardi, D; Vianello, F; Iacobone, M; Corvò, R; Magrini, Sm; Pappagallo, G; Arcangeli, S; D'Angelillo, Rm Articolo su rivista
1-gen-2002 Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial Trodella, L; Granone, P; Valente, S; Valentini, V; Balducci, M; Mantini, G; Turriziani, A; Margaritora, S; Cesario, A; Ramella, S; Corbo, G; D'Angelillo, R; Fontana, A; Galetta, D; Cellini, N Articolo su rivista
1-gen-2004 Adjuvant therapy of melanoma patients (Stage II, III): a pilot immuno-toxicological study Tricarico, M; Nunziata, C; Atzori, F; Concolino, F; Macchini, V; D'Atri, S; Prete, Sp; Turriziani, M; Lanzilli, G; Sera, F; Abeni, D; Albanesi, V; Bonmassar, E; Pagani, E Articolo su rivista
1-gen-2018 Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis Grenga, I; Donahue, Rn; Gargulak, Ml; Lepone, Lm; Roselli, M; Bilusic, M; Schlom, J Articolo su rivista
1-gen-2007 Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancer. Franchi, F; Grassi, P; Ferro, D; Pigliucci, Gm; De Chicchis, M; Castigliani, G; Pastore, C; Seminara, P Articolo su rivista
30-ago-2023 Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives Sganga, S; Riondino, S; Iannantuono, Gm; Rosenfeld, R; Roselli, M; Torino, F Articolo su rivista
8-giu-2013 The antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro Adamo, R; Comandini, A; Aquino, A; Bonmassar, L; Guglielmi, L; Bonmassar, E; Franzese, O Articolo su rivista
1-gen-2017 Antitumour activity of resveratrol on human melanoma cells: A possible mechanism related to its interaction with malignant cell telomerase Platella, C; Guida, S; Bonmassar, L; Aquino, A; Bonmassar, E; Ravagnan, G; Montesarchio, D; Roviello, G; Musumeci, D; Fuggetta, M Articolo su rivista
1-gen-2023 Applications of large language models in cancer care: current evidence and future perspectives Iannantuono, Gm; Bracken-Clarke, D; Floudas, Cs; Roselli, M; Gulley, Jl; Karzai, F Articolo su rivista
1-gen-2015 Are there alternative ways to quantify the real benefit of novel agents in oncology? - The 'death pace' Formica, V; Montefusco, E; Roselli, M Articolo su rivista
1-gen-2018 Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy? D'Angelillo, R; Ramella, S Articolo su rivista
Mostrati risultati da 1 a 20 di 394
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile